Ameriprise Financial Inc Vertex Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,225,307 shares of VRTX stock, worth $1.01 Billion. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,225,307

Previous 2,510,029 11.34%

Holding current value

$1.01 Billion

Previous $1.02 Billion 8.92%

% of portfolio

0.26%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $116 Million - $127 Million	-284,722 Reduced 11.34%	2,225,307 $930 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $147 Million - $176 Million	-427,783 Reduced 14.56%	2,510,029 $1.02 Billion
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $29.1 Million - $31.2 Million	-86,031 Reduced 2.85%	2,937,812 $1.02 Billion
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $115 Million - $129 Million	-366,017 Reduced 10.8%	3,023,843 $1.06 Billion
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $53.5 Million - $61 Million	-188,787 Reduced 5.28%	3,389,860 $1.07 Billion

Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $132 Million - $149 Million	-463,346 Reduced 11.46%	3,578,647 $1.03 Billion
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $143 Million - $159 Million	-520,956 Reduced 11.42%	4,041,993 $1.17 Billion
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $90.3 Million - $112 Million	-384,414 Reduced 7.77%	4,562,949 $1.29 Billion
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $116 Million - $137 Million	524,167 Added 11.85%	4,947,363 $1.29 Billion
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $183 Million - $231 Million	1,034,106 Added 30.51%	4,423,196 $969 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $118 Million - $132 Million	650,315 Added 23.74%	3,389,090 $615 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $154 Million - $181 Million	820,708 Added 42.79%	2,738,775 $552 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $228 Million - $266 Million	1,100,467 Added 134.6%	1,918,067 $412 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $4.61 Million - $6.15 Million	-22,268 Reduced 2.65%	817,600 $193 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $114 Million - $135 Million	-444,227 Reduced 34.59%	839,868 $228 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $200 Million - $263 Million	-888,799 Reduced 40.9%	1,284,095 $373 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $47.2 Million - $58.5 Million	-236,171 Reduced 9.8%	2,172,894 $517 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $5.05 Million - $6.78 Million	30,299 Added 1.27%	2,409,065 $527 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $10.5 Million - $11.8 Million	-62,955 Reduced 2.58%	2,378,766 $403 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $12.9 Million - $14.9 Million	78,258 Added 3.31%	2,441,721 $448 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $325 Million - $387 Million	-1,986,539 Reduced 45.67%	2,363,463 $435 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $212 Million - $268 Million	-1,393,382 Reduced 24.26%	4,350,002 $721 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $13.8 Million - $15.8 Million	-82,081 Reduced 1.41%	5,743,384 $1.11 Billion
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $32.1 Million - $37.5 Million	220,446 Added 3.93%	5,825,465 $988 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $53 Million - $61.9 Million	349,639 Added 6.65%	5,605,019 $914 Million
Q4 2017 Feb 12, 2018	SELL	$137.28 - $155.55 $24.3 Million - $27.5 Million	-176,700 Reduced 3.25%	5,255,380 $787 Million
Q3 2017 Nov 07, 2017	BUY	$148.13 - $162.24 $805 Million - $881 Million	5,432,080	5,432,080 $826 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Vertex Pharmaceuticals Inc Transaction History